Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
iTonic HoldingsITOC 14 EV-to-EBITDA is -0.81 as of Aug. 05, 2026. GuruFocus rates ITOC with a GF Score™ of 14/100. The stock has 6 warning signs investors should review. Among 512 Medical Devices & Instruments companies, iTonic Holdings ranks worse than 195312.3% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, iTonic Holdings's enterprise value is $4.17 Mil.
iTonic Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $-5.15 Mil. Therefore, iTonic Holdings's EV-to-EBITDA for today is -0.81.
The historical rank and industry rank for iTonic Holdings's EV-to-EBITDA or its related term are showing as below:
ITOC'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -618.48 Med: -8.31 Max: 0.39
Current: -0.81
During the past 5 years, the highest EV-to-EBITDA of iTonic Holdings was 0.39. The lowest was -618.48. And the median was -8.31.
ITOC's EV-to-EBITDA is ranked worse than 100% of 512
companies
in the Medical Devices & Instruments industry
Industry Median: 14.485
vs ITOC: -0.81
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
iTonic Holdings's PE Ratio (TTM) for today is calculated as:
iTonic Holdings's share price for today is $0.29.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. iTonic Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.318.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for iTonic Holdings's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ITOC vs USAQ, ALURD, INBS: EV-to-EBITDA Comparison
For the Medical Devices subindustry, iTonic Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iTonic Holdings EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, iTonic Holdings's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where iTonic Holdings's EV-to-EBITDA falls into.
iTonic Holdings's current Enterprise Value is $4.17 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. iTonic Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $-5.15 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
iTonic Holdings (ITOC) has a EV-to-EBITDA of -0.81 as of Aug. 05, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on iTonic Holdings. According to the industry distribution chart, iTonic Holdings ranks #999999 out of 512 companies in the Medical Devices & Instruments industry.
Is iTonic Holdings' EV-to-EBITDA too high?
iTonic Holdings' current EV-to-EBITDA is -0.81. Based on the distribution chart, iTonic Holdings ranks #999999 out of 512 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, iTonic Holdings has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does iTonic Holdings' EV-to-EBITDA compare to USAQ and ALURD?
According to the Medical Devices & Instruments industry distribution chart, iTonic Holdings ranks #999999 out of 512 companies for EV-to-EBITDA. This places iTonic Holdings in the lower half of its industry. The industry median EV-to-EBITDA is 14.49. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.49, based on 512 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on iTonic Holdings. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iTonic Holdings's current EV-to-EBITDA is -0.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iTonic Holdings stock overvalued right now?
iTonic Holdings (ITOC) has a current EV-to-EBITDA of -0.81. The current EV-to-EBITDA is -0.81. iTonic Holdings' overall GF Score™ is 14/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For iTonic Holdings (ITOC), the current EV-to-EBITDA is -0.81 as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its product, Beijing Feitian's Treatment Planning System, helps ensure safe and effective brachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors. Its product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device, etc.
14GF Score
Get the complete analysis for ITOC
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ITOC has been successfully added to your 
